Skip to content

Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome

Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02582957
Acronym
SiVent
Enrollment
524
Registered
2015-10-21
Start date
2016-04-01
Completion date
2022-10-08
Last updated
2024-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Keywords

ARDS, Shock Lung, Acute Chest Syndrome, Respiratory Distress Syndrome, Adult, Respiratory insufficiency, Trauma

Brief summary

A randomized, concurrent controlled trial to assess if adding sigh breaths to usual invasive mechanical ventilation of victims of trauma who are at risk of developing ARDS will decrease the number of days they require invasive mechanical ventilation.

Detailed description

Patients in intensive care units (ICUs) as a result of injuries resulting from penetrating or non-penetrating trauma who are intubated and receiving invasive mechanical ventilation will be randomized to either usual care or usual care with the addition of sigh breaths given once every 6 minutes. Patients will be randomized to one of the two study arms as soon as possible, but not longer than 24 hours after initiation of invasive mechanical ventilation. Patients will be followed for 28 days to assess ventilator-free days (VFDs), mortality, ICU-free days, and the occurrence of complications.

Interventions

Sigh breaths delivered once every 6 minutes, as part of usual invasive mechanical ventilation.

Sponsors

United States Department of Defense
CollaboratorFED
University of Colorado, Denver
CollaboratorOTHER
University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

Patients in an intensive care unit (ICU) as a result of injuries resulting from penetrating or non-penetrating trauma who are intubated and receiving invasive mechanical ventilation who also have one or more of the following: 1. Traumatic brain injury 2. \> 1 long bone fractures 3. Shock on arrival in the Emergency Department (systolic BP \< 90 mmHg) 4. Lung contusion 5. Receipt of \> 6 units of blood

Exclusion criteria

1. Inability to obtain consent from the patient or his/her legally authorized representative (LAR) 2. Unwillingness of the treating physician to use sigh ventilation as all treating physicians must have equipoise with respect to the intervention 3. Age limitations per Institutional Review Board regulations 4. Undergoing invasive mechanical ventilation for \> 24 hours, excluding any time during which the patient was being ventilated in the operating room, CT or IR, as this could represent too long a delay in instituting the intervention for it to have a chance of being effective 5. Presence of malignancy or other irreversible disease or condition for which the six month mortality is estimated to exceed 50% (e.g., chronic liver disease with a Child-Pugh Score of 10-15, malignancy refractory to treatment) as this could affect the clinical course and cloud interpretation of the endpoints 6. Women who are pregnant (negative pregnancy tests required on women of child-bearing age) per Human Subjects regulations 7. Prisoners, per Human Subjects regulations 8. Neurological condition that could impair spontaneous ventilation (e.g., C5 or higher spinal cord injury as this could affect the clinical course and cloud interpretation of the ventilator-free day endpoint 9. Lack of availability of Dräger Evita Infinity V500 ventilator as this is the only ventilator capable of delivering sigh breaths as described in the protocol 10. Burns \> 40% of body surface area as this could affect the clinical course and cloud interpretation of the endpoints 11. Treating physicians being unwilling to use low VT ventilation strategy when ARDS is diagnosed as low VT ventilation is now considered standard of care for patients with ARDS. 12. Moribund, not expected to survive 24 hours as this could affect the clinical course and cloud interpretation of the endpoints13. Treating physician's decision to use airway pressure release ventilation (APRV). 13. Patient not expected to require mechanical ventilation \> 24 hours (e.g., intubated for alcohol intoxication rather than pulmonary problem).

Design outcomes

Primary

MeasureTime frameDescription
Ventilator-free Days (VFDs)28 daysVentilator-free days (VFDs), defined as the number of days of unassisted breathing to day 28 without having to re-institute invasive ventilation. Patients who died before day 28 were assigned 0 VFDs as were those transferred to a long-term care facility while ventilated.

Secondary

MeasureTime frameDescription
All-cause Mortality28 daysAll-cause 28 day mortality
ICU-free Days28 daysNumber of ICU-free days to day 28 after enrollment
Number of Participants With Complications of Treatment28 daysSpecifically the number of participants experiencing pneumothorax, ventilator-associated pneumonia, hypotension requiring pressors, or pneumatoceles.
Discharge Status28 daysPercentage of patients discharged to extended care facilities, on mechanical ventilation, or to in-patient or home hospice
Number of Participants Requiring Oxygen Therapy at Discharge28 daysNumber of Participants newly requiring continuous oxygen therapy at discharge.

Countries

United States

Participant flow

Recruitment details

Patients were recruited in 15 trauma centers in the United States from April, 2016, to September, 2022.

Pre-assignment details

All analyses were based on the intention-to-treat principle. Participants were included in the primary analysis if primary endpoint data was available (ventilator-free days (VFDs), defined as the number of days of unassisted breathing to day 28 without having to re-institute invasive ventilation).

Participants by arm

ArmCount
Sigh Breaths
Sigh breaths consisting of a Tidal volume (VT) that produces a plateau pressure (Pplat) of 35 cmH2O (or 40 cmH2O in patients with BMIs \> 35 or in patients with moderate or severe abdominal distension from ascites, blood and/or ileum, or prone patients). The sigh breaths will be delivered once every 6 minutes, as part of usual invasive mechanical ventilation. Sigh breaths: Sigh breaths delivered once every 6 minutes, as part of usual invasive mechanical ventilation.
261
Usual Care
Usual care, meaning that the treating physician will be free to treat the patient in any way he or she sees fit, including utilizing invasive mechanical ventilation as they wish.
263
Total524

Baseline characteristics

CharacteristicTotalUsual CareSigh Breaths
Age, Continuous
Age
43.9 years
STANDARD_DEVIATION 19.2
44.2 years
STANDARD_DEVIATION 19.2
43.7 years
STANDARD_DEVIATION 19.1
Arterial blood gas FIO247.6 mmHg
STANDARD_DEVIATION 18.1
47.1 mmHg
STANDARD_DEVIATION 17.2
48.2 mmHg
STANDARD_DEVIATION 18.9
Arterial blood gas PaCO238.9 mmHg
STANDARD_DEVIATION 7.6
38.6 mmHg
STANDARD_DEVIATION 7.8
39.1 mmHg
STANDARD_DEVIATION 7.4
Arterial blood gas PaO2154.9 mmHg
STANDARD_DEVIATION 82
152.5 mmHg
STANDARD_DEVIATION 79.9
157.4 mmHg
STANDARD_DEVIATION 84.2
Arterial blood gas pH7.36 pH
STANDARD_DEVIATION 0.08
7.37 pH
STANDARD_DEVIATION 0.08
7.36 pH
STANDARD_DEVIATION 0.08
BMI28.5 kg/m^2
STANDARD_DEVIATION 6.5
28.4 kg/m^2
STANDARD_DEVIATION 6.5
28.7 kg/m^2
STANDARD_DEVIATION 6.4
Ethnicity (NIH/OMB)
Hispanic or Latino
85 Participants42 Participants43 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
439 Participants221 Participants218 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Hours on ventilator prior to randomization17.0 hours
STANDARD_DEVIATION 5.8
17.0 hours
STANDARD_DEVIATION 5.9
17.1 hours
STANDARD_DEVIATION 5.8
Injury Severity Score29.4 units on a scale
STANDARD_DEVIATION 12.3
29.9 units on a scale
STANDARD_DEVIATION 11.7
28.8 units on a scale
STANDARD_DEVIATION 12.9
P/F ratio349.2 Ratio
STANDARD_DEVIATION 193.8
349.8 Ratio
STANDARD_DEVIATION 214
347.6 Ratio
STANDARD_DEVIATION 172
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants0 Participants2 Participants
Race (NIH/OMB)
Asian
5 Participants4 Participants1 Participants
Race (NIH/OMB)
Black or African American
107 Participants52 Participants55 Participants
Race (NIH/OMB)
More than one race
3 Participants3 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants1 Participants1 Participants
Race (NIH/OMB)
White
405 Participants203 Participants202 Participants
Region of Enrollment
United States
524 participants263 participants261 participants
Sex: Female, Male
Female
130 Participants66 Participants64 Participants
Sex: Female, Male
Male
394 Participants197 Participants197 Participants
Smoking status
Current/Past
237 Participants103 Participants134 Participants
Smoking status
Never
145 Participants80 Participants65 Participants
Smoking status
Unknown/Missing
142 Participants80 Participants62 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
30 / 25946 / 261
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
103 / 259114 / 261

Outcome results

Primary

Ventilator-free Days (VFDs)

Ventilator-free days (VFDs), defined as the number of days of unassisted breathing to day 28 without having to re-institute invasive ventilation. Patients who died before day 28 were assigned 0 VFDs as were those transferred to a long-term care facility while ventilated.

Time frame: 28 days

Population: Analysis based on participants with available follow-up data

ArmMeasureValue (MEDIAN)
Sigh BreathsVentilator-free Days (VFDs)18.4 days
Usual CareVentilator-free Days (VFDs)16.1 days
Secondary

All-cause Mortality

All-cause 28 day mortality

Time frame: 28 days

Population: Analysis population based on those with follow-up data available

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Sigh BreathsAll-cause Mortality30 Participants
Usual CareAll-cause Mortality46 Participants
Secondary

Discharge Status

Percentage of patients discharged to extended care facilities, on mechanical ventilation, or to in-patient or home hospice

Time frame: 28 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Sigh BreathsDischarge Status6 Participants
Usual CareDischarge Status5 Participants
Secondary

ICU-free Days

Number of ICU-free days to day 28 after enrollment

Time frame: 28 days

Population: Analysis based on participants with available follow-up data

ArmMeasureValue (MEDIAN)
Sigh BreathsICU-free Days13.7 days
Usual CareICU-free Days11.9 days
Secondary

Number of Participants Requiring Oxygen Therapy at Discharge

Number of Participants newly requiring continuous oxygen therapy at discharge.

Time frame: 28 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Sigh BreathsNumber of Participants Requiring Oxygen Therapy at Discharge20 Participants
Usual CareNumber of Participants Requiring Oxygen Therapy at Discharge12 Participants
Secondary

Number of Participants With Complications of Treatment

Specifically the number of participants experiencing pneumothorax, ventilator-associated pneumonia, hypotension requiring pressors, or pneumatoceles.

Time frame: 28 days

Population: Analysis based on participants with available follow-up data

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Sigh BreathsNumber of Participants With Complications of TreatmentPneumothorax18 Participants
Sigh BreathsNumber of Participants With Complications of TreatmentHypotension requiring pressors127 Participants
Sigh BreathsNumber of Participants With Complications of TreatmentVentilator-associated pneumonia57 Participants
Sigh BreathsNumber of Participants With Complications of TreatmentPneumatocele1 Participants
Usual CareNumber of Participants With Complications of TreatmentPneumatocele2 Participants
Usual CareNumber of Participants With Complications of TreatmentPneumothorax20 Participants
Usual CareNumber of Participants With Complications of TreatmentVentilator-associated pneumonia69 Participants
Usual CareNumber of Participants With Complications of TreatmentHypotension requiring pressors120 Participants

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026